<DOC>
	<DOCNO>NCT02521402</DOCNO>
	<brief_summary>The main purpose study see clinical benefit use Biovance reduction recurrence keloid use revise . It also assess postoperative complication .</brief_summary>
	<brief_title>Pilot Study Evaluate Clinical Outcomes With Use Biovance Following Keloid Scar Revision Surgery</brief_title>
	<detailed_description>To assess performance Biovance , patient consult regard history previous treatment keloid . Once patient deem appropriate candidate , enrol study . Operatively , old scar completely excise . Then Biovance lay base wound . After perform , extensive undermine do close wound layer . All post-revision complication ( include infection , incision dehiscence , hematoma , seroma , wound necrosis ) assess record investigator . Patients review obtain demographic risk factor ( age , body mass index , smoke ) data . Data adjuvant therapy use ( previous surgery , treatment keloid scar ) collect . Surgical technique detail ( incision size closure technique ) also record patient . Photographs document pre- , intra- post-revision clinical course patient collect .</detailed_description>
	<mesh_term>Keloid</mesh_term>
	<criteria>The subject : 1. diagnose keloid scar 2. keloid scar locate face , neck , arm , trunk , groin area 3. age 21 80 year old 4. competency adult , per applicable state law willing provide write informed consent 5. intent ability return schedule required visit follow recommended standard post surgical treatment keloid scar excision . The subject : 1. clinical evidence infection keloid scar 2. malignancy neoplasm keloid scar site 3. significant comorbid disease may interfere wound healing , know active Hepatitis A , B , C Acquired Immune Deficiency Syndrome know infected HIV , know collagen disorder autoimmune disease [ include systemic lupus erythematosis ( SLE ) , rheumatoid arthritis ( RA ) , fibromyalgia , polymyositis , scleroderma , ankylose spondylitis , dermatomyositis , osteogenesis imperfecta inherit disorder Sjogren , Larsen , Raynaud , EhlersDanlos Marfan syndrome ] 4. receive chemotherapy , radiotherapy , immunosuppressives corticosteroid ( great 10 mg prednisoneequivalent per day ) within past 30 day . 5. known history abuse alcohol drug ( prescribed illegal ) , significant psychiatric personality psychotic disorder require chronic psychotropic therapy , gross noncompliance recommend therapy 6. condition ( ) would adversely affect subject safety follow protocol 7. contraindication use Biovance</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>